Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Neuroscience ; 190: 37-42, 2011 Sep 08.
Article in English | MEDLINE | ID: mdl-21683126

ABSTRACT

Previously selected amyloid beta recognizing heavy chain antibody fragments (VHH) affinity binders derived from the Camelid heavy chain antibody repertoire were tested for their propensity to cross the blood-brain barrier (BBB) using an established in vitro BBB co-culture system. Of all tested VHH, ni3A showed highest transmigration efficiency which is, in part, facilitated by a three amino acid substitutions in its N-terminal domain. Additional studies indicated that the mechanism of transcellular passage of ni3A is by active transport. As VHH ni3A combines the ability to recognize amyloid beta and to cross the BBB, it has potential as a tool for non-invasive in vivo imaging and as efficient local drug targeting moiety in patients suffering from cerebral amyloidosis such as Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA).


Subject(s)
Amyloid beta-Peptides/immunology , Blood-Brain Barrier/metabolism , Brain/metabolism , Immunoglobulin Heavy Chains/metabolism , Alzheimer Disease/metabolism , Biological Transport/physiology , Down Syndrome/metabolism , Humans , Immunoglobulin Fragments/metabolism
2.
Neurology ; 66(2 Suppl 1): S86-92, 2006 Jan 24.
Article in English | MEDLINE | ID: mdl-16432153

ABSTRACT

Frameshift (+1) proteins such as APP(+1) and UBB(+1) accumulate in sporadic cases of Alzheimer disease (AD) and in older subjects with Down syndrome (DS). We investigated whether these proteins also accumulate at an early stage of neuropathogenesis in young DS individuals without neuropathology and in early-onset familial forms of AD (FAD), as well as in other tauopathies, such as Pick disease (PiD) or progressive supranuclear palsy (PSP). APP(+1) is present in many neurons and beaded neurites in very young cases of DS, which suggests that it is axonally transported. In older DS patients (>37 years), a mixed pattern of APP(+1) immunoreactivity was observed in healthy looking neurons and neurites, dystrophic neurites, in association with neuritic plaques, as well as neurofibrillary tangles. UBB(+1) immunoreactivity was exclusively present in AD type of neuropathology. A similar pattern of APP(+1) and UBB(+1) immunoreactivity was also observed for FAD and much less explicit in nondemented controls after the age of 51 years. Furthermore, we observed accumulation of +1 proteins in other types of tauopathies, such as PiD, frontotemporal dementia, PSP and argyrophylic grain disease. These data suggest that accumulation of +1 proteins contributes to the early stages of dementia and plays a pathogenic role in a number of diseases that involve the accumulation of tau.


Subject(s)
Alzheimer Disease/genetics , Frameshift Mutation , Tauopathies/genetics , Adult , Aged , Aged, 80 and over , Alzheimer Disease/metabolism , Amino Acid Substitution , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Cerebral Cortex/chemistry , Cerebral Cortex/ultrastructure , Down Syndrome/genetics , Down Syndrome/metabolism , Female , Genes, Dominant , Hippocampus/chemistry , Hippocampus/ultrastructure , Humans , Immunoenzyme Techniques , Male , Membrane Proteins/genetics , Middle Aged , Nerve Degeneration/genetics , Nerve Degeneration/metabolism , Pedigree , Presenilin-1 , Tauopathies/metabolism , Ubiquitin/genetics , Ubiquitin/metabolism
3.
Neurology ; 63(12): 2396-8, 2004 Dec 28.
Article in English | MEDLINE | ID: mdl-15623710

ABSTRACT

Whether autoimmune mechanisms play a role in the pathogenesis of inclusion body myositis (IBM) is unknown. Human leukocyte antigen (HLA) analysis in 52 patients, including 17 with autoimmune disorders (AIDs), showed that patients were more likely to have antigens from the autoimmune-prone HLA-B8-DR3 ancestral haplotype than healthy control subjects, irrespective of the presence of AIDs. Patients lacked the apparently protective HLA-DR53 antigen. The results provide further support for an autoimmune basis in IBM.


Subject(s)
Autoimmune Diseases/epidemiology , Genes, MHC Class II , Genes, MHC Class I , HLA Antigens/analysis , HLA-D Antigens/analysis , Myositis, Inclusion Body/epidemiology , Age of Onset , Aged , Aged, 80 and over , Autoimmune Diseases/genetics , Autoimmune Diseases/immunology , Comorbidity , Female , Gene Frequency , Genetic Predisposition to Disease , HLA Antigens/genetics , HLA Antigens/immunology , HLA-D Antigens/genetics , HLA-D Antigens/immunology , HLA-DR Antigens/analysis , HLA-DR Antigens/genetics , HLA-DR Antigens/immunology , HLA-DRB4 Chains , Haplotypes/genetics , Humans , Male , Middle Aged , Myositis, Inclusion Body/genetics , Myositis, Inclusion Body/immunology , Netherlands/epidemiology , Prevalence
4.
Ann N Y Acad Sci ; 977: 149-54, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12480745

ABSTRACT

Cerebrovascular deposition of the amyloid beta-protein (Abeta) is a common pathologic event in patients with Alzheimer's disease (AD) and certain related disorders. Such an Abeta vascular deposition occurs primarily in the medial layer of the cerebral vessel wall in an assembled fibrillar state. These deposits are associated with several pathological responses, including degeneration of the smooth muscle cells in the cerebral vessel wall. Severe cases of cerebrovascular Abeta deposition are also accompanied by loss of vessel wall integrity and hemorrhagic stroke. Although the reasons for this pathological consequence are unclear, altered proteolytic mechanisms within the cerebral vessel wall may be involved. We analyzed cerebral Abeta deposition in brains with AD and Dutch-type hereditary cerebral hemorrhage with amyloidosis (HCHWA-D) on the basis of two amyloid species of Abeta(40) and Abeta(42/43) using specific monoclonal antibodies. Compared to Abeta deposition in senile plaques, the molecular composition of Abeta was distinguishable, indicating that the Abeta(40) species is the main component for vascular amyloid. Furthermore, we found Abeta(42/43) immunoreactivity was also much increased in amyloid angiopathy of all cases with HCHWA-D. Taken together, amyloid angiopathy in HCHWA-D may share an Abeta(42)-driven deposition mechanism with plaque amyloid, resulting in enhanced Abeta(40) deposition.


Subject(s)
Amyloid beta-Peptides/genetics , Amyloidosis, Familial/genetics , Amyloidosis, Familial/pathology , Cerebral Hemorrhage/genetics , Cerebrovascular Circulation/physiology , Peptide Fragments/genetics , Animals , COS Cells , Cerebral Hemorrhage/pathology , Chlorocebus aethiops , Humans , Mice , Mutation , Netherlands , Sweden , Transfection
5.
Acta Neuropathol ; 102(6): 604-14, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11761721

ABSTRACT

Cerebrovascular deposition of amyloid beta protein (A beta) is a characteristic lesion of Alzheimer's disease (AD) and hereditary cerebral hemorrhage with amyloidosis of the Dutch type (HCHWA-D). Besides A beta, several other proteins and proteoglycans accumulate in cerebral amyloid angiopathy (CAA). We have now analyzed the expression of the heparan sulfate proteoglycan (HSPG) subtypes agrin, perlecan, glypican-1, syndecans 1-3 and HS glycosaminoglycan (GAG) side chains in CAA in brains of patients with AD and HCHWA-D. Hereto, specific well-characterized antibodies directed against the core protein of these HSPGs and against the GAG side chains were used for immunostaining. Glypican-1 was abundantly expressed in CAA both in AD and HCHWA-D brains, whereas perlecan and syndecans-1 and -3 were absent in both. Colocalization of agrin with vascular A beta was clearly observed in CAA in HCHWA-D brains, but only in a minority of the AD cases. Conversely, syndecan-2 was frequently associated with vascular A beta in AD, but did not colocalize with vascular A beta deposits in HCHWA-D. The three different syndecans, agrin, glypican-1 and HS GAG, but not perlecan, were associated with the majority of senile plaques (SPs) in all brains. Our results suggest a role for agrin in the formation of SPs and of CAA in HCHWA-D, but not in the pathogenesis of CAA in AD. Both syndecan-2 and glypican, but not perlecan, may be involved in the formation of CAA. We conclude that specific HSPG species may be involved in the pathogenesis of CAA in both AD and HCHWA-D, and that the pathogenesis of CAA and SPs may differ with regard to the involvement of HSPG species.


Subject(s)
Alzheimer Disease/pathology , Brain/blood supply , Brain/pathology , Cerebral Amyloid Angiopathy, Familial/pathology , Cerebral Arteries/pathology , Heparan Sulfate Proteoglycans/metabolism , Plaque, Amyloid/metabolism , Plaque, Amyloid/pathology , Agrin/metabolism , Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/metabolism , Cerebral Amyloid Angiopathy, Familial/physiopathology , Cerebral Arteries/physiopathology , Female , Glycosaminoglycans/metabolism , Glypicans , Humans , Immunohistochemistry , Male , Membrane Glycoproteins/metabolism , Middle Aged , Proteoglycans/metabolism , Syndecans
6.
Ann Neurol ; 50(6): 765-72, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11761474

ABSTRACT

Cerebral amyloid angiopathy is frequently found in demented and nondemented elderly persons, but its contribution to the causation of dementia is unknown. Therefore, we investigated the relation between the amount of cerebral amyloid angiopathy and the presence of dementia in 19 patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type. The advantage of studying hereditary cerebral hemorrhage in amyloidosis-Dutch type is that patients with this disease consistently have severe cerebral amyloid angiopathy with minimal neurofibrillary pathology. The amount of cerebral amyloid angiopathy, as quantified by computerized morphometry, was strongly associated with the presence of dementia independent of neurofibrillary pathology, plaque density, or age. The number of cortical amyloid beta-laden severely stenotic vessels, vessel-within-vessel configurations, and cerebral amyloid angiopathy-associated microvasculopathies was associated with the amount of cerebral amyloid angiopathy and dementia. A semiquantitative score, based on the number of amyloid beta-laden severely stenotic vessels, completely separated demented from nondemented patients. These results suggest that extensive (more than 15 amyloid beta-laden severely stenotic vessels in five frontal cortical sections) cerebral amyloid angiopathy alone is sufficient to cause dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type. This may have implications for clinicopathological correlations in Alzheimer's disease and other dementias with cerebral amyloid angiopathy.


Subject(s)
Cerebral Amyloid Angiopathy, Familial/pathology , Cerebral Cortex/pathology , Cerebral Hemorrhage/genetics , Dementia/pathology , Neurofibrillary Tangles/pathology , Aged , Aged, 80 and over , Blood Vessels/pathology , Cerebral Amyloid Angiopathy, Familial/physiopathology , Cerebral Cortex/blood supply , Cerebral Hemorrhage/pathology , Cerebral Hemorrhage/physiopathology , Dementia/physiopathology , Humans , Middle Aged , Plaque, Amyloid/pathology , Severity of Illness Index , Statistics as Topic
7.
J Neuropathol Exp Neurol ; 59(8): 723-32, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10952062

ABSTRACT

To clarify where and how beta-amyloid begins to deposit in senile plaques, we examined the ultrastructural localization of amyloid beta protein (Abeta) in diffuse plaques of brains with hereditary cerebral hemorrhage with amyloidosis-Dutch type. Alzheimer disease (AD), and from nondemented aged subjects. Serial ultrathin sections of osmium-plastic blocks were immunogold-labeled for Abetax-42 (Abeta42), and sections on grids were observed under the electron microscope (EM) after observing the exact localization of the diffuse plaques in sections on glass slides by the reflection contrast microscope. Abeta42 deposition, which was decollated with gold particles, appeared in 3 forms in all subjects under the EM: 1) Scattered small bundles of amyloid fibrils between cell processes, frequently seen in the densely stained area of diffuse plaques. 2) Scattered small foci of nonfibrillar materials between cell processes as a relatively minor form. 3) Abeta42 on a part of the cell surface plasma membrane of normal appearing cell processes, a major form in weakly immunostained areas. The last form was not associated with degenerative neurites or reactive glia. Abeta42 deposition on the cell surface plasma membrane appears to be an initial event in diffuse plaques, and then it develops into amorphous/fibrillar amyloid between cell processes.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Amyloidosis/complications , Brain/metabolism , Cerebral Hemorrhage/genetics , Cerebral Hemorrhage/metabolism , Aged , Aged, 80 and over , Alzheimer Disease/pathology , Amyloidosis/pathology , Brain/pathology , Cell Membrane/metabolism , Cerebellum/pathology , Cerebral Hemorrhage/complications , Cerebral Hemorrhage/pathology , Frontal Lobe/pathology , Humans , Microscopy, Electron , Middle Aged , Plaque, Amyloid/metabolism , Plaque, Amyloid/pathology , Reference Values
8.
Acta Neuropathol ; 99(4): 409-19, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10787040

ABSTRACT

The evolvement of amyloid beta (Abeta) deposition in the frontal cerebral cortex of 24 patients of increasing age with Dutch-type hereditary cerebral hemorrhage with amyloidosis (HCHWA-D) was studied using end-specific monoclonal antibodies to Abetax-42 (Abeta42) or Abetax-40 (Abeta40) and markers for degenerating neurites. Abeta42 immunostaining revealed parenchymal Abeta deposits with a heterogeneous morphology and distribution, i.e., clouds, fine/dense diffuse, coarse, and homogeneous plaques. Clouds and diffuse plaques were associated with glial Abeta granules. Abeta40 labeling was absent in clouds/fine diffuse plaques, inconsistent and variably intense in dense diffuse/coarse plaques and consistent in homogeneous plaques. In a subset of Abeta40-positive plaques, degenerating neurites--without tauopathy--and/or amyloid cores were observed. Electron microscopy revealed no apparent amyloid fibrils in fine diffuse plaques, small bundles of fibrils in dense diffuse/homogeneous plaques, and amyloid masses in coarse plaques. The parenchymal Abeta pathology was age-related: the ratio of fine to dense diffuse plaques decreased with age, clouds were limited to younger patients; coarse plaques to the oldest old. Homogeneous/cored plaques were present most consistently in older patients. Plaque density did not increase with age. Vascular Abeta deposits stained for both Abeta species, but exclusively Abeta42-positive, presumably recent deposits were also observed. This study suggests that HCHWA-D is a model of plaque evolution in which clouds leave fine diffuse plaques, which may become dense diffuse and ultimately coarse or homogeneous plaques.


Subject(s)
Aging/pathology , Amyloid beta-Peptides/analysis , Amyloidosis/pathology , Brain Diseases, Metabolic, Inborn/pathology , Cerebral Amyloid Angiopathy/pathology , Cerebral Hemorrhage/genetics , Cerebral Hemorrhage/pathology , Plaque, Amyloid/pathology , Adult , Aged , Aged, 80 and over , Brain/pathology , Brain/ultrastructure , Cerebral Arteries/pathology , Cerebral Arteries/ultrastructure , Female , Humans , Male , Middle Aged , Neurites/pathology , Neurites/ultrastructure , Neuroglia/pathology , Plaque, Amyloid/ultrastructure
10.
Acta Neuropathol ; 98(6): 577-82, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10603032

ABSTRACT

The C-terminal profile and ultrastructure of small and presumably early capillary amyloid beta protein (Abeta) deposits were investigated in four patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type. The C terminus of the 40 (Abeta40) or the 42 (Abeta42) amino acid form of Abeta was gold labeled in serial, ultrathin sections on glass slides for reflection contrast microscopy and on grids for electron microscopy. In all studied subjects, reflection contrast microscopy revealed capillaries with focal Abeta42 immunolabeling in the absence of Abeta40 labeling. In the adjacent electron microscopic section, Abeta42 labeling was confined to the capillary basement membrane. The majority of Abeta42(+)40(-) deposits showed no amyloid fibrils. Abeta42(+)40(-) deposits were sometimes observed in an unremarkable basement membrane but usually showed increased electron density and reticular structures. A small subset of Abeta42(+)40(-) deposits with basement membrane changes showed few amyloid fibrils. Abeta42(+)40(+) capillary deposits always showed definite fibrils and were larger than Abeta42(+)40(-) capillary deposits. The present findings suggest that in capillaries the accumulation and subsequent polymerization of Abeta42, possibly in conjunction with basement membrane changes, precedes the definite fibril formation with Abeta40.


Subject(s)
Amyloid beta-Peptides/analysis , Basement Membrane/pathology , Basement Membrane/ultrastructure , Cerebral Amyloid Angiopathy/pathology , Cerebral Amyloid Angiopathy/physiopathology , Cerebral Hemorrhage/pathology , Cerebral Hemorrhage/physiopathology , Endothelium, Vascular/pathology , Endothelium, Vascular/ultrastructure , Peptide Fragments/analysis , Aged , Humans , Middle Aged
11.
Philos Trans R Soc Lond B Biol Sci ; 354(1386): 1061-7, 1999 Jun 29.
Article in English | MEDLINE | ID: mdl-10434306

ABSTRACT

Huntington's disease (HD) is a neurodegenerative disorder with a midlife onset. The disease is caused by expansion of a CAG (glutamine) repeat within the coding region of the HD gene. The molecular mechanism by which the mutated protein causes this disease is still unclear. To study the protein we have generated a set of rabbit polyclonal antibodies raised against different segments of the N-terminal, central and C-terminal parts of the protein. The polyclonal antibodies were affinity purified and characterized in ELISA and Western blotting experiments. All antibodies can react with mouse and human proteins. The specificity of these antibodies is underscored by their recognition of huntingtin with different repeat sizes in extracts prepared from patient-derived lymphoblasts. The antibodies were used in immunofluorescence experiments to study the subcellular localization of huntingtin in mouse neuroblastoma NIE-115 cells. The results indicate that most huntingtin is present in the cytoplasm, whereas a minor fraction is present in the nucleus. On differentiation of the NIE-115 cells in vitro, the subcellular distribution of huntingtin does not change significantly. These results suggest that full-length huntingtin with a normal repeat length can be detected in the nucleus of cycling and non-cycling cultured mammalian cells of neuronal origin. However, in HD autopsy brain the huntingtin-containing neuronal intranuclear inclusions can be detected only with antibodies raised against the N-terminus of huntingtin. Thus several forms of huntingtin display the propensity for nuclear localization, possibly with different functional consequences.


Subject(s)
Brain/pathology , Huntington Disease/pathology , Nerve Tissue Proteins/analysis , Neurons/pathology , Nuclear Proteins/analysis , Animals , Antibodies , Cell Differentiation , Humans , Huntingtin Protein , Huntington Disease/genetics , Mice , Nerve Tissue Proteins/genetics , Neuroblastoma , Neurons/cytology , Nuclear Proteins/genetics , Rabbits , Recombinant Fusion Proteins/analysis , Subcellular Fractions/metabolism , Subcellular Fractions/pathology , Transfection , Tumor Cells, Cultured
12.
Brain Res ; 828(1-2): 179-83, 1999 May 15.
Article in English | MEDLINE | ID: mdl-10320740

ABSTRACT

To determine the presence and distribution of cerebrovascular Abeta production we investigated amyloid beta precursor protein (AbetaPP)-mRNA expression by RNA in situ hybridization in patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type, Alzheimer disease and controls. In all subjects, AbetaPP-mRNA was expressed in endothelial cells, smooth muscle cells, adventitial cells and brain pericytes and/or perivascular cells. Meningeal cells also expressed AbetaPP-mRNA. AbetaPP was detected in endothelial cells, smooth muscle cells and adventitial cells. The demonstration of AbetaPP-mRNA at all vascular sites where amyloid formation can occur supports an important contribution of locally derived Abeta to cerebrovascular amyloidosis.


Subject(s)
Amyloid beta-Protein Precursor/genetics , Cerebral Amyloid Angiopathy/genetics , Cerebral Hemorrhage/genetics , Aged , Aged, 80 and over , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Brain/blood supply , Brain/metabolism , Cerebral Amyloid Angiopathy/metabolism , Cerebral Angiography , Cerebral Arteries/chemistry , Cerebral Arteries/physiology , Cerebral Hemorrhage/metabolism , Gene Expression , Humans , In Situ Hybridization , Middle Aged , RNA, Messenger/analysis
13.
Acta Neuropathol ; 97(5): 533-9, 1999 May.
Article in English | MEDLINE | ID: mdl-10334493

ABSTRACT

Lewy bodies (LB) and pale bodies (PB), their putative precursors, can be found in a spectrum of diseases characterized by parkinsonism and/or dementia. Furthermore, LB are occasionally observed in some other neurodegenerative diseases and in normal aging. Classical LB are typically found in the brain stem, especially in the substantia nigra, where these inclusions are associated with neuronal loss and clinical signs of idiopathic Parkinson's disease (PD). The so-called cortical LB occur in the cerebral cortex, amygdala and claustrum with little or no neuronal loss and are clinically associated with dementia in dementia with LB (DLB). We describe a patient without apparent clinical signs of parkinsonism and/or dementia, whose brain contained numerous classical-like LB, pale inclusions with features of PB and transitions between these two. These inclusions had similar immunohistological (ubiquitin positive; neurofilament positive; tau negative) and ultrastructural features as the LB in PD and DLB except for the lack of immunoreactivity for alpha-synuclein. The pons and cerebral cortex showed the highest number of LB, up to 165/1.76 mm2. These numbers were contrasted by the lack of obvious neuronal loss or gliosis. The absence of alpha-synuclein reactivity in the LB in this symptomless patient corroborates the hypothesis that alpha-synuclein accumulation in LB is an important step in neurodegeneration in PD and DLB, but tones down the role of alpha-synuclein in LB formation in general. This patient seems to represent a new variant in the spectrum of diseases associated with LB.


Subject(s)
Lewy Bodies/pathology , Nerve Tissue Proteins/analysis , Parkinson Disease/pathology , Brain/pathology , Humans , Male , Middle Aged , Synucleins , alpha-Synuclein
14.
J Neuropathol Exp Neurol ; 58(2): 129-37, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10029096

ABSTRACT

Recently, an N-terminal fragment of huntingtin was localized to neuronal intranuclear inclusions (NII), presumed to cause cellular dysfunction, and to inclusions in dystrophic neurites (IDN) in the neostriatum and neocortex of Huntington disease (HD) patients. In the present immunohistochemical study of autopsy brain of 2 juvenile-onset HD patients, 5 HD patients with adult-onset, and 5 controls, NII and IDN as stained with both N-terminal antiserum to huntingtin and ubiquitin antiserum were detected in the HD neostriatum, neocortex, and allocortex, but not in the HD pallidum, cerebellum, and substantia nigra nor in control brain. The frequency of NII in the HD neocortex was highest in the juvenile patients. Within the allocortex, NII and IDN were found in the entorhinal region, subiculum, and pyramidal cell layer of Ammon's horn. N-terminal huntingtin antiserum also labeled intranuclear granular structures adjacent to the neuronal nuclear membrane in 5 HD patients, one control with idiopathic epilepsy, and one with Alzheimer disease. Our results show that NII formation in HD involves the allocortex in addition to the neostriatum and neocortex. The development of NII in the neocortex and allocortex in HD brain might contribute to the emergence of the cognitive and behavioral symptoms of the disease.


Subject(s)
Cell Nucleus/pathology , Huntington Disease/pathology , Inclusion Bodies/pathology , Neurites/pathology , Pyramidal Cells/pathology , Adolescent , Adult , Aged , Antibodies, Antinuclear , Basal Ganglia/cytology , Basal Ganglia/pathology , Blotting, Western , Cell Nucleus/chemistry , Cell Nucleus/immunology , Cerebellum/cytology , Cerebellum/pathology , Child , Cytoplasm/chemistry , Female , Humans , Huntingtin Protein , Immunohistochemistry , Inclusion Bodies/chemistry , Inclusion Bodies/immunology , Male , Middle Aged , Neocortex/cytology , Neocortex/pathology , Nerve Tissue Proteins/analysis , Nerve Tissue Proteins/immunology , Neurites/chemistry , Nuclear Proteins/analysis , Nuclear Proteins/immunology , Pyramidal Cells/chemistry , Pyramidal Cells/ultrastructure , Substantia Nigra/cytology , Substantia Nigra/pathology , Ubiquitins/analysis
15.
Stroke ; 29(8): 1588-94, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9707198

ABSTRACT

BACKGROUND AND PURPOSE: Microvascular changes such as microaneurysms and fibrinoid necrosis have been found in the presence of cerebral amyloid angiopathy (CAA). These CAA-associated microvasculopathies (CAA-AM) may contribute to the development of CAA-associated hemorrhages and/or infarcts, hereafter referred to as "cerebrovascular lesions." Hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D) is an autosomal dominant form of CAA, in which the amyloid angiopathy is pathologically and biochemically similar to sporadic CAA associated with aging and Alzheimer disease. To determine the significance of CAA-AM for CAA-associated cerebrovascular complications, we investigated the association between CAA-AM and cerebrovascular lesions in HCHWA-D patients. METHODS: In a previous autopsy study we semiquantitatively scored CAA-AM in 29 HCHWA-D patients. In the present study we reviewed clinical charts and autopsy protocols of these same patients. We investigated whether CAA-AM was associated with age at death, number of cerebrovascular lesions, duration of clinical illness, hypertension, and atherosclerosis. RESULTS: An association was found between CAA-AM and the number of cerebrovascular lesions (P = 0.009). The presence of microaneurysmal degeneration was most strongly associated with the number of cerebrovascular lesions (P < 0.001). In addition, we found an association between atherosclerosis and the CAA-AM score (P = 0.047). Hypertension was not associated with CAA-AM. CONCLUSIONS: Our findings support previous reports suggesting an important role of secondary microvascular degenerative changes in CAA-associated cerebrovascular lesions and suggest an aggravating effect of systemic atherosclerosis, but not hypertension, on the evolution of CAA-AM. These findings may be of relevance to understanding cerebrovascular complications of sporadic or Alzheimer disease-associated CAA.


Subject(s)
Brain/blood supply , Cerebral Amyloid Angiopathy/pathology , Cerebral Hemorrhage/pathology , Age Factors , Aged , Aged, 80 and over , Arteriosclerosis/complications , Arteriosclerosis/pathology , Capillaries/pathology , Cerebral Amyloid Angiopathy/genetics , Cerebral Amyloid Angiopathy/mortality , Cerebral Hemorrhage/genetics , Cerebral Hemorrhage/mortality , Cerebrovascular Disorders/etiology , Cerebrovascular Disorders/genetics , Cerebrovascular Disorders/pathology , Female , Humans , Hypertension/complications , Hypertension/pathology , Intracranial Aneurysm/complications , Intracranial Aneurysm/pathology , Male , Microcirculation , Middle Aged
16.
Ned Tijdschr Geneeskd ; 142(11): 553-7, 1998 Mar 14.
Article in Dutch | MEDLINE | ID: mdl-9623110

ABSTRACT

In 3 patients, a 72-year-old man, a 62-year-old man and a 73-year-old woman with weakness of respectively the quadriceps femoris, the finger flexors and the pharyngeal muscles, the diagnosis of 'inclusion body myositis' was made. This is a rare, slowly progressive skeletal muscle disorder which is more common in men and after the age of fifty. The activity of serum creatine kinase is often 2-5 times the highest normal value. The electromyogram pattern is myopathic, but can also display neuropathic changes (exclusively). Inclusion body myositis is often misdiagnosed, which can lead to an inappropriate treatment or approach. A frozen muscle biopsy is needed to make cryostat sections for demonstration of myositis with rimmed vacuoles.


Subject(s)
Muscle Weakness/etiology , Myositis, Inclusion Body/diagnosis , Aged , Biomarkers/blood , Biopsy , Creatine Kinase/blood , Electromyography , Female , Humans , Male , Middle Aged , Muscle, Skeletal/pathology , Myositis, Inclusion Body/complications , Myositis, Inclusion Body/enzymology
17.
Acta Neuropathol ; 95(3): 235-44, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9542588

ABSTRACT

Various secondary microvascular degenerative and inflammatory alterations may complicate cerebral amyloid angiopathy (CAA) and contribute to the morbidity of CAA-associated stroke. We have investigated the severity of CAA-associated microangiopathy in a genetically determined Dutch form of CAA (HCHWA-D) that has major similarities to the type of CAA that more commonly occurs with aging or Alzheimer's disease (AD). The presence and extent of the following vascular abnormalities was assessed: (1) hyalinization/fibrosis, (2) microaneurysm formation, (3) chronic (especially lymphocytic) inflammation, (4) perivascular multinucleated giant cells/granulomatous angiitis, (5) macrophages/histiocytes within the vessel wall, (6) vessel wall calcification, (7) fibrinoid necrosis, and (8) mural or occlusive thrombi. (Of these, calcification of CAA-affected vessel walls has, to our knowledge, been described in only a single patient with CAA-associated cerebral hemorrhage.) Some of the changes, such as histiocytes in blood vessel walls and the relationship of vascular hyalinosis to amyloid beta/A4 protein deposition, were highlighted by immunohistochemistry. By assessing the numbers of sections in which the changes were present for each case, a 'score' reflective of CAA-associated angiopathy could be obtained. This 'score' was reproducible among several observers. We suggest that it might also be applicable to quantifying severe CAA and related microvascular degenerative changes in patients with AD. beta/A4 immunoreactivity was often sparse and adventitial (or almost absent) in severely hyalinized arterioles and microaneurysms. However, macrophages were prominent in the walls of such vessels and may play a role in the pathogenesis and progression of CAA-related microvasculopathy.


Subject(s)
Brain/blood supply , Brain/pathology , Cerebral Amyloid Angiopathy/pathology , Cerebral Hemorrhage/pathology , Amyloid beta-Peptides/analysis , Antigens, Nuclear , Biomarkers , Capillaries/chemistry , Capillaries/pathology , Cerebral Arteries/chemistry , Cerebral Arteries/pathology , Humans , Macrophages/physiology , Nuclear Proteins/analysis
18.
Ann Neurol ; 41(5): 695-8, 1997 May.
Article in English | MEDLINE | ID: mdl-9153536

ABSTRACT

Hereditary cerebral hemorrhage with amyloidosis-Dutch type is caused by a mutation at codon 693 of the beta amyloid precursor protein gene. The disease is clinically characterized by strokes and dementia. In addition to cerebral plaques, cerebral amyloid angiopathy is the pathological hallmark. We investigated the correlation between radiological (white matter hyperintensities and focal lesions on magnetic resonance images) and pathological lesions (cerebrovascular amyloid angiopathy and plaques) and the apolipoprotein E genotype in patients with the disease. Twenty-five patients were studied using magnetic resonance imaging, and brain tissue from 8 patients was studied histopathologically. Neither the white matter hyperintensity scores nor the number of focal lesions on magnetic resonance images were associated with the presence of an epsilon4 allele. Nor was a correlation found between the number and type of plaques and the apolipoprotein E genotype. All patients had severe amyloid angiopathy in all cortical areas investigated. This study showed that the apolipoprotein E genotype does not modulate amyloid-related structural lesions in hereditary cerebral hemorrhage with amyloidosis of the Dutch type.


Subject(s)
Apolipoproteins E/genetics , Cerebral Amyloid Angiopathy/genetics , Cerebral Amyloid Angiopathy/pathology , Adult , Aged , Aged, 80 and over , Brain/pathology , Cerebral Amyloid Angiopathy/ethnology , Cerebral Cortex/pathology , Female , Genotype , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Multivariate Analysis , Mutation , Netherlands/epidemiology
19.
J Neuropathol Exp Neurol ; 56(3): 273-84, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9056541

ABSTRACT

Arterial and arteriolar amyloid-beta (A beta) deposition in hereditary cerebral hemorrhage with amyloidosis (Dutch) (HCHWA-D) and Alzheimer disease (AD) cerebral amyloid angiopathy (CAA) were studied as to morphology, extent, and association with mononuclear phagocyte system (MPS) cells using A beta, a-smooth muscle actin, and monocyte/macrophage marker (HLA-DR, CD68, CD11c, CD45) immunohistochemistry. The HCHWA-D/AD arterial/arteriolar media showed compact A beta deposits, first appearing at the media/adventitia junction, and concomitant smooth muscle loss. Only HCHWA-D CAA featured (a) severe involvement of larger arteries and (b) arterioles showing a single or double ring of radial A beta surrounding compact A beta. Radial A beta appeared to develop at the media/adventitia junction. Monocyte/macrophage marker-positive foci/cells co-localized with HCHWA-D arterial A beta. Focal HLA-DR/CD11c positivity was observed at the media/adventitia junction of AD/HCHWA-D arteries in the absence of local A beta, but not in controls. Monocyte/macrophage marker positivity co-localizing with radial A beta appeared continuous with perivascular cells and microglia clustering perivascularly. These results suggest that (a) MPS cells are topographically associated with HCHWA-D arterial A beta and radial arteriolar A beta, and (b) HLA-DR/CD11c immunoreactivity may appear at the media/adventitia junction prior to A beta. The latter finding and the assumed formation of radial A beta at the media/adventitia junction may relate to involvement of the abluminal basement membrane in CAA pathogenesis. The role of MPS cells in this process remains to be established.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Protein Precursor/metabolism , Amyloidosis/metabolism , Cerebral Hemorrhage/metabolism , Phagocytes/metabolism , Adult , Aged , Cerebral Hemorrhage/genetics , Female , Humans , Male , Middle Aged
20.
Am J Pathol ; 148(4): 1257-66, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8644866

ABSTRACT

Amyloid (A beta) deposition was investigated in cases of Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis, Dutch type, due to mutations in the amyloid precursor protein (APP) gene using the end-specific monoclonal antibodies BA27 and BC05 that recognize A beta 40 or A beta 42(43), respectively. In cases of APP717 mutation the predominant A beta species within plaques terminate at A beta 42(43) with relatively little A beta 40 being present. The total amount of A beta deposited as A beta 42(43) is significantly greater than in sporadic Alzheimer's disease, consistent with the suggestion that this mutation might influence the processing of APP so as to produce more of the highly aggregatable form, A beta 1-42. In cases of APP670/671 mutation the major peptide in plaques is also A beta 42(43), although the proportion of plaques containing A beta 40, and the total A beta load is similar to that in sporadic Alzheimer's disease. As in sporadic Alzheimer's disease, the vascular amyloid in APP670/671 and APP717 and in cases of hereditary cerebral hemorrhage with amyloidosis, Dutch type is predominantly A beta 40 in this latter disorder, however, parenchymal deposits are exclusively A beta 42(43). Although the various APP mutations may influence the type, quantity, and location of A beta deposited, the predominant, and possibly the initial, species deposited in the brain parenchyma is A beta 42(43).


Subject(s)
Alzheimer Disease/pathology , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Cerebral Hemorrhage/pathology , Mutation , Neurofibrillary Tangles/pathology , Adult , Aged , Aged, 80 and over , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Amino Acid Sequence/genetics , Cerebral Hemorrhage/genetics , Cerebral Hemorrhage/metabolism , Female , Humans , Immunohistochemistry , Male , Middle Aged , Neurofibrillary Tangles/genetics , Neurofibrillary Tangles/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...